Consequently, based on this evidence, it is crucial for studies on the action of G-1 on breast cancer cells to consider both its effects on GPER and related signaling pathways and its non-GPER-dependent tumor inhibitory effect. The gene discussed is GPER1; the disease is neoplasm.